GCPII-IN-1 TFA is a peptide-like inhibitor scaffold targeting glutamate carboxypeptidase II in biochemical assays. Carboxylate and amide groups mimic key substrate interactions within the active site. Researchers assess binding constants, catalytic suppression, and structural complementarity by enzymology and docking. Applications include enzyme-mechanism elucidation, inhibitor-design research, and neurochemical pathway studies.
CAT No: R2721
CAS No:1269794-89-9
Synonyms/Alias:GCPII-IN-1 TFA;GCPII-IN-1 (TFA);1269794-89-9;(2S)-2-[[(1S)-5-amino-1-carboxypentyl]carbamoylamino]pentanedioic acid;2,2,2-trifluoroacetic acid;EX-A10938;HY-139840A;DA-73673;MS-27735;CS-0255869;E72657;(((S)-5-Amino-1-carboxypentyl)carbamoyl)-L-glutamic acid compound with 2,2,2-trifluoroacetic acid (1:1);
Gcpii-IN-1 tfa, a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII), is a small molecule compound renowned for its high affinity and specificity towards the GCPII enzyme. Structurally designed to interact with the active site of GCPII, Gcpii-IN-1 tfa demonstrates robust inhibitory activity, making it a valuable tool for researchers investigating the biological roles of GCPII in various physiological and pathological processes. Its stability and solubility in aqueous environments further enhance its utility in a wide range of experimental settings, from in vitro biochemical assays to more complex cellular models. Researchers benefit from its well-characterized profile, which facilitates reproducibility and confidence in experimental outcomes, particularly in studies aiming to elucidate the enzymatic pathways involving GCPII.
Neuroscience research: In the field of neuroscience, Gcpii-IN-1 tfa is extensively utilized to probe the functional significance of GCPII in the central nervous system. By selectively inhibiting GCPII, scientists can modulate the levels of N-acetylaspartylglutamate (NAAG) and glutamate, two critical neurotransmitters involved in synaptic transmission and neuroprotection. This targeted approach enables the dissection of GCPII's role in neurophysiological processes such as synaptic plasticity, neurotransmitter balance, and excitotoxicity, thereby providing valuable insights into the molecular mechanisms underlying neurological disorders. The compound's precise mode of action allows for controlled experimental manipulation, which is essential for isolating the contributions of GCPII to neural function and dysfunction.
Molecular pharmacology: Within molecular pharmacology, Gcpii-IN-1 tfa serves as a reference inhibitor in the characterization of new compounds targeting GCPII. Its well-documented inhibitory kinetics and selectivity profile make it an ideal benchmark for comparative studies, enabling researchers to evaluate the efficacy and specificity of novel GCPII inhibitors. Through these comparative analyses, the compound supports the rational design and optimization of next-generation inhibitors with improved pharmacological properties. Additionally, its application in competitive binding assays and enzyme kinetics studies aids in delineating the structure-activity relationships governing GCPII inhibition, thus advancing the field of enzyme-targeted drug discovery.
Enzyme activity assays: Gcpii-IN-1 tfa is frequently employed in enzyme activity assays to quantify the activity of GCPII under various experimental conditions. By introducing the inhibitor into assay systems, researchers can distinguish between GCPII-dependent and independent enzymatic processes, thereby enhancing the specificity and interpretability of their results. This approach is particularly valuable in complex biological samples where multiple carboxypeptidase activities may coexist. The ability to selectively inhibit GCPII also facilitates the validation of assay methodologies and the development of more accurate detection platforms for GCPII activity, which are essential for advancing basic and translational research.
Biochemical pathway elucidation: In studies focused on biochemical pathway elucidation, the use of Gcpii-IN-1 tfa enables scientists to map the downstream effects of GCPII inhibition on cellular metabolism and signaling networks. By blocking GCPII activity, researchers can observe changes in metabolite profiles, signal transduction cascades, and gene expression patterns, thereby uncovering the broader biological consequences of modulating this enzyme. These investigations are instrumental in identifying novel targets and pathways that may be implicated in disease pathogenesis or therapeutic intervention, highlighting the compound's significance in systems biology and integrative research approaches.
Chemical biology tool development: As a chemical biology tool, Gcpii-IN-1 tfa is invaluable for the development and validation of new research methodologies. Its predictable inhibitory properties and compatibility with diverse assay formats make it an essential reagent in the toolkit of chemical biologists. The compound is often incorporated into high-throughput screening protocols, probe validation studies, and mechanism-of-action investigations, where it serves as a positive control or reference standard. By enabling precise modulation of GCPII activity, it facilitates the exploration of enzyme function in both isolated and complex biological systems, ultimately contributing to the advancement of innovative experimental strategies and the discovery of novel biological insights.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More